Direct reprogramming: Defying the contemporary limitations in cardiac regeneration

June 22, 2020

Direct reprogramming or Transdifferentiation is a way of inducing changes in the cell type from one lineage into another lineage, bypassing pluripotency. This approach is an innovative choice to replace the lost cardiomyocytes after an end-stage myocardial infraction because transplantation is the only feasible remedial option at present. According to the World Health Organization (WHO) estimates, a staggering 17.9 million casualties are reported worldwide each year due to myocardial infarction. It is also the leading cause of death, with an estimated 31% of all deaths globally, which clearly outlines the inadequacies in the current cardiac therapy.

Today, only a handful of cell therapy-based strategies that include induced pluripotent stem cells, embryonic stem cells, bone marrow, liposuction, heart biopsies are known to restore the function of cardiomyocytes after myocardial infarction. Yet, the risks associated with the cell therapy-based strategies necessitate an alternative strategy that satisfies all standards necessary for safe and efficacious reprogramming. To overcome the perils of iPSC cell-based therapies, transdifferentiation of cardiac fibroblasts using microRNAs (miRNAs, miRs) hold a promising role in repair and regeneration. Extensive research in this regard has made it possible to identify an ideal reprogramming cocktail for high yield of reprogrammed cells. However, there is no ideal strategy available with an optimal delivery method for genetic reprogramming.

Researchers from Bio-Nano Electronics Research Centre (BNERC), Toyo University, Japan, present a review that provides an overview and understanding of the direct reprogramming strategies focusing on the merits and the limitations of the strategies. The review also discusses various miRNA delivery strategies for safe, effective, and sustained delivery to achieve better tissue repair with a primary focus on biomaterials like electrospun scaffolds and nanoparticles as potential non-viral vectors. The reviewers emphasize that customized biomaterial-based scaffolds with miRNA not only co-exist with the tissue by providing an intramyocardial cellular environment but also provides precision control of miRNA release that may be crucial for direct cardiac reprogramming. The review has been published in Current Pharmaceutical Design.
-end-
For more information, please visit: http://www.eurekaselect.com/180536/article

Bentham Science Publishers

Related Myocardial Infarction Articles from Brightsurf:

Treatment shows reduction in heart failure after myocardial infarction
Researchers at Baylor College of Medicine identified potential preventative therapies for heart failure after a significant heart attack.

The challenges of treating acute myocardial infarction due to variant angina
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.1262, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, China, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China and Shandong First Medical University, Tai'an, China consider the challenges of treating acute myocardial infarction due to variant angina.

WeChat group of chest pain center for patients with acute ST-segment elevation myocardial infarction
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0590, Liu Yue, Qin Zhu-Yun, Yang Xin, Tang Rong and Gao Ling-Yun from the The First Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the use of a social media platform (WeChat) to provide faster treatment and improve prognoses for a group of patients with acute ST-segment Elevation Myocardial Infarction.

Improved survival after obesity operation in patients with previous myocardial infarction
Researchers at Karolinska Institutet and Danderyd Hospital in Sweden have studied the risk of additional myocardial infarctions and early death in severely obese patients who undergo metabolic surgery following a myocardial event.

Researchers discover a cell type responsible for cardiac repair after infarction
The researcher of the Faculty of Science of the UMA Adrián Ruiz-Villalba, who is also member of the Andalusian Center for Nanomedicine and Biotechnology (BIONAND) and the Biomedical Research Institute of Malaga (IBIMA), is the first author of an international study that has identified the heart cells in charge of repairing the damage caused to this organ after infarction.

Discovery of cells that heal cardiac damage after infarction
Researchers at Cima and the Clinica Universidad de Navarra (Spain) have led an international study identifying the cardiac cells responsible for repairing the damage to this organ after infarction.

CHOP researchers find MIS-C associated with myocardial injury
Using sensitive parameters to assess cardiac function, researchers at Children's Hospital of Philadelphia (CHOP) have found that cardiac involvement in multisystem inflammatory syndrome in children (MIS-C) differs from Kawasaki disease (KD) and is associated with myocardial injury.

Heart attack modeled with human stem cells
A model of ischemic heart disease was developed using human induced pluripotent stem cells (hiPSC).

The relationship between lifetime drinking and non-fatal acute myocardial infarction
New research from the Prevention Research Center of the Pacific Institute for Research and Evaluation suggests that the impact of alcohol consumption on coronary heart disease may be underestimated.

The relationship between mean platelet volume and in-hospital mortality in geriatric patients with ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Read More: Myocardial Infarction News and Myocardial Infarction Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.